Skip to main content
YUNGJIN PHARM. CO., LTD logo

YUNGJIN PHARM. CO., LTD — Investor Relations & Filings

Ticker · 003520 ISIN · KR7003520004 KO Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2023-03-06 Audit Report / Informat…
Country KR South Korea
Listing KO 003520

About YUNGJIN PHARM. CO., LTD

https://eng.yungjin.co.kr/

Yungjin Pharm. Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products for domestic and international markets. The company's portfolio includes a range of prescription drugs, with a focus on areas such as cephalosporin antibiotics and antipsychotic medications. Yungjin Pharm is actively involved in advancing its R&D pipeline, which includes collaborative research for treatments of rare conditions like mitochondrial diseases. Leveraging extensive drug production expertise and R&D capabilities, the company operates as a key affiliate within the KT&G Group's bio/pharmaceutical business.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing (1337 characters) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion, key financial figures, and the auditor's name, but it is an announcement of the submission of the audit report to the regulatory body rather than the full, comprehensive audit report document itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement. FY 2022
2023-03-06 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Youngjin Pharm. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits). This type of document is a standard proxy solicitation material sent to shareholders to inform them of upcoming meeting details and voting items, which falls under the Proxy Solicitation & Information Statement category.
2023-03-06 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Audit Report / Information Classification · 95% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by a subsidiary (Youngjin Pharm) under the KT&G corporate group. It details share ownership, inter-company transactions, and financial relationships within the corporate group as required by Korean fair trade regulations. Since this is a specific regulatory disclosure regarding corporate structure and group status that does not fit into financial reporting (10-K/IR) or other specific categories, it is classified as a Regulatory Filing (RNS). Q1 2024
2023-02-27 Korean
투자판단관련주요경영사항
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Youngjin Pharm regarding a legal matter. It specifically details the company's decision to file an appeal against a first-instance court ruling in a damages lawsuit. Since the document reports on a significant legal proceeding and its status, it falls under the 'Legal Proceedings Report' category.
2023-02-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Youngjin Pharm) announcing a significant change in financial results (revenue or profit structure change of 30% or more). This is a standard preliminary earnings announcement required by the Korea Exchange (KRX) before the final audited annual report is filed. Since it provides key financial highlights and performance metrics rather than the full annual report, it is classified as an Earnings Release (ER). FY 2022
2023-02-08 Korean
소송등의판결ㆍ결정(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a court judgment (lawsuit) involving Youngjin Pharm. It details the case name, the amount of damages awarded, the court, and the company's planned response. This fits the definition of a Legal Proceedings Report (LTR), which covers significant lawsuits and regulatory actions.
2023-02-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.